trending Market Intelligence /marketintelligence/en/news-insights/trending/2lp2dfxyuctly_4xfl7atw2 content esgSubNav
In This List

Easton Pharmaceuticals adds board member

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Easton Pharmaceuticals adds board member

Easton Pharmaceuticals Inc. appointed Daniel Bagi to its board.

Bagi will also be president of business development.

He recently helped the company and its Latin American joint venture partner BMV Medica SA de CV secure a sub-licensing deal with with Bayer AG for VS-Sense, a bacterial vaginosis diagnostic product, for Mexico.